D1 Capital Partners L.P. Charles River Laboratories International, Inc. Transaction History
D1 Capital Partners L.P.
- $4.81 Billion
- Q1 2025
A detailed history of D1 Capital Partners L.P. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, D1 Capital Partners L.P. holds 777,489 shares of CRL stock, worth $116 Million. This represents 2.43% of its overall portfolio holdings.
Number of Shares
777,489
Previous 935,820
16.92%
Holding current value
$116 Million
Previous $173 Million
32.26%
% of portfolio
2.43%
Previous 3.8%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
610Shares Held
54.5MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$908 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$757 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$637 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$356 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$341 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.57B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...